Development of Biomarkers of Transient Ischemic Attack

Abstract

Abstract:

Transient ischemic attack (TIA) is an early-warning alarm for stroke. As of yet, no known blood marker reliably predicts stroke risk after TIA. The present research focuses on TIA biomarkers to identify high risk patients rapidly and accurately. In this article, we provide a review on the development of TIA biomarkers involving stress hormones, inflammatory factors, thrombosis factors. Meanwhile, the paper gives a brief introduction about gene sequencing and metabonomics methods in the application of stroke risk prediction after TIA.

Key words: Transient ischemic attack; Stroke; Proediction; Biomarkers

摘要：

短暂性脑缺血发作（transient ischemic attack，TIA）是卒中的危险预警信号。至今尚无公认的对卒中风险预测价值高的TIA的生物学标志物。寻找快速而准确的TIA后卒中风险的生物学标志物是目前研究的热点。本文从应激激素、炎症因子、血栓形成因子等方面对TIA后卒中风险的生物学标志物研究进行综述，并简要介绍基因测序及代谢组学等方法在TIA后卒中风险预测中的应用。

关键词: 短暂性脑缺血发作; 卒中; 预测; 标志物

PEI Lu-Lu, FANG Hui, ZHAO Lu, XU Yu-Ming, SONG Bo.. Development of Biomarkers of Transient Ischemic Attack[J]. Chinese Journal of Stroke, 2015, 10(05): 442-446.

裴璐璐，方慧，赵璐，许予明，宋波. 短暂性脑缺血发作生物学标志物研究进展[J]. 中国卒中杂志, 2015, 10(05): 442-446.

References

1 Kokubo Y. Epidemiology of transient ischemic attack[J]. Front Neurol Neurosci, 2014, 33:69-81.

2 Giles MF, Rothwell PM. Risk of stroke early after transient ischaemic attack:a systematic review and meta-analysis[J]. Lancet Neurol, 2007, 6:1063-1072.

3 Johnston SC, Rothwell PM, Nguyen-Huynh MN, et al. Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack[J]. Lancet, 2007, 369:283-292.

4 Amarenco P, Labreuche J, Lavallee PC. Patients with transient ischemic attack with ABCD2<4 can have similar 90-day stroke risk as patients with transient ischemic attack with ABCD2>/=4[J]. Stroke, 2012, 43:863-865.

5 Perry JJ, Sharma M, Sivilotti ML, et al. Prospective validation of the ABCD2 score for patients in the emergency department with transient ischemic attack[J]. CMAJ, 2011, 183:1137-1145.

6 Merwick A, Albers GW, Amarenco P, et al. Addition of brain and carotid imaging to the ABCD2 score to identify patients at early risk of stroke after transient ischaemic attack:a multicentre observational study[J]. Lancet Neurol, 2010, 9:1060-1069.

7 Neidert S, Katan M, Schuetz P, et al. Anterior pituitary axis hormones and outcome in acute ischaemic stroke[J]. J Intern Med, 2011, 269:420-432.

8 Katan M, Fluri F, Morgenthaler NG, et al. Copeptin:a novel, independent prognostic marker in patients with ischemic stroke[J]. Ann Neurol, 2009, 66:799-808.

9 Katan M, Nigro N, Fluri F, et al. Stress hormones predict cerebrovascular re-events after transient ischemic attacks[J]. Neurology, 2011, 76:563-566.

10 De Marchis GM, Weck A, Audebert H, et al. Copeptin for the prediction of recurrent cerebrovascular events after transient ischemic attack:results from the CoRisk study[J]. Stroke, 2014, 45:2918-2923.

11 Tobin MK, Bonds JA, Minshall RD, et al. Neurogenesis and inflammation after ischemic stroke:what is known and where we go from here[J]. J Cereb Blood Flow Metab, 2014, 34:1573-1584.

12 Emerging Risk Factors Collaboration, Kaptoge S, Di Angelantonio E, et al. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality:an individual participant meta-analysis[J]. Lancet, 2010, 375:132-140.

13 Purroy F, Montaner J, Molina CA, et al. C-reactive protein predicts further ischemic events in transient ischemic attack patients[J]. Acta Neurol Scand, 2007, 115:60-66.

14 Corso G, Bottacchi E, Brusa A, et al. Blood C-reactive protein concentration with ABCD(2) is a better prognostic tool than ABCD(2) alone[J]. Cerebrovasc Dis, 2011, 32:97-105.

15 Cucchiara B L, Messe SR, Sansing L, et al. Lipoprotein-associated phospholipase A2 and C-reactive protein for risk-stratification of patients with TIA[J]. Stroke, 2009, 40:2332-2336.

16 Cai A, Zheng D, Qiu R, et al. Lipoprotein-associated phospholipase A2 (Lp-PLA[2]):a novel and promising biomarker for cardiovascular risks assessment[J]. Dis Markers, 2013, 34:323-331.

17 Vittos O, Toana B, Vittos A, et al. Lipoprotein-associated phospholipase A2 (Lp-PLA2):a review of its role and significance as a cardiovascular biomarker[J]. Biomarkers, 2012, 17:289-302.

18 Massot A, Pelegri D, Penalba A, et al. Lipoprotein-associated phospholipase A2 testing usefulness among patients with symptomatic intracranial atherosclerotic disease[J]. Atherosclerosis, 2011, 218:181-187.

19 Delgado P, Chacon P, Penalba A, et al. Lipoprotein-associated phospholipase A(2) activity is associated with large-artery atherosclerotic etiology and recurrent stroke in TIA patients[J]. Cerebrovasc Dis, 2012, 33:150-158.

20 Whiteley W, Jackson C, Lewis S, et al. Inflammatory markers and poor outcome after stroke:a prospective cohort study and systematic review of interleukin-6[J]. PLoS Med, 2009, 6:e1000145.

21 Simundic AM, Basic V, Topic E, et al. Soluble adhesion molecules in acute ischemic stroke[J]. Clin Invest Med, 2004, 27:86-92.

22 Selvarajah JR, Smith CJ, Hulme S, et al. Does inflammation predispose to recurrent vascular events after recent transient ischaemic attack and minor stroke? The North West of England transient ischaemic attack and minor stroke (NORTHSTAR) study[J]. Int J Stroke, 2011, 6:187-194.

23 Whiteley W, Wardlaw J, Dennis M, et al. The use of blood biomarkers to predict poor outcome after acute transient ischemic attack or ischemic stroke[J]. Stroke, 2012, 43:86-91.

24 Mustonen P, Lehtonen KV, Javela K, et al. Persistent antiphospholipid antibody (aPL) in asymptomatic carriers as a risk factor for future thrombotic events:a nationwide prospective study[J]. Lupus, 2014, 23:1468-1476.

25 Mullen MT, Messe SR, Kasner SE, et al. Anti-phosphatidylserine-prothrombin antibodies are associated with outcome in a TIA cohort[J]. Front Neurol, 2012, 3:137.

26 De Meyer SF, Stoll G, Wagner DD, et al. von Willebrand factor:an emerging target in stroke therapy[J]. Stroke, 2012, 43:599-606.

27 Di Castelnuovo A, Agnoli C, De Curtis A, et al. Elevated levels of D-dimers increase the risk of ischaemic and haemorrhagic stroke. Findings from the EPICOR Study[J]. Thromb Haemost, 2014, 112:941-946.

28 Segal HC, Burgess AI, Poole DL, et al. Population-based study of blood biomarkers in prediction of subacute recurrent stroke[J]. Stroke, 2014, 45:2912-2917.

29 Greisenegger S, Segal HC, Burgess AI, et al. Biomarkers and mortality after transient ischemic attack and minor ischemic stroke:population-based study[J]. Stroke, 2015, 46:659-666.

30 Mauri-Capdevila G, Jove M, Suarez-Luis I, et al. Metabolomics in ischaemic stroke, new diagnostic and prognostic biomarkers[J]. Rev Neurol, 2013, 57:29-36.

31 Jiang Z, Sun J, Liang Q, et al. A metabonomic approach applied to predict patients with cerebral infarction[J]. Talanta, 2011, 84:298-304.

32 Zhan X, Jickling G C, Tian Y, et al. Transient ischemic attacks characterized by RNA profiles in blood[J]. Neurology, 2011, 77:1718-1724.

33 Jove M, Mauri-Capdevila G, Suarez I, et al. Metabolomics predicts stroke recurrence after transient ischemic attack[J]. Neurology, 2015, 84:36-45.

[1]	MA Junwen, BAI Chengping. The Correlation of Serum Inflammatory Factors and Cerebrovascular Reactivity with Cognitive Impairment in Patients with Transient Ischemic Attack [J]. Chinese Journal of Stroke, 2022, 17(12): 1314-1320.
[2]	LU Yan, YANG Baorong, HUANG Xiangping, YANG Guangui, CHEN Shengwen, LI Jianrong, ZENG Xiaoming. MRI-Guided Thrombolysis beyond Time Window in Acute Ischemic Stroke in a County-Level Hospital: A Case-Control Study [J]. Chinese Journal of Stroke, 2022, 17(12): 1321-1326.
[3]	CHU Yueqi, ZHOU Kaiyun, WANG Tianyan, WANG Jiongbin, LI Zhen. The Efficacy of Auricular Acupuncture Pressing for Post-Stroke Dysphagia: A Meta-Analysis [J]. Chinese Journal of Stroke, 2022, 17(12): 1327-1334.
[4]	ZHOU Tiantian, SU Wenjie, LIAN Songyong, LIN Youcong. Effects of Environmental Enrichment on Cognitive Function in Patients with Vascular Dementia after Stroke [J]. Chinese Journal of Stroke, 2022, 17(12): 1343-1349.
[5]	WU Yuqian, ZHANG Yumei, FAN Xiaowei, WANG Anxin, PANG Wenbin. The Efficacy of Kinesthetic Motor Imagery Therapy for Hand Function Rehabilitation of Stroke Patients [J]. Chinese Journal of Stroke, 2022, 17(12): 1366-1371.
[6]	JIANG Lin, LI Jing. Science Mapping Analysis of Artificial Intelligence Applied in Stroke Research [J]. Chinese Journal of Stroke, 2022, 17(12): 1372-1380.
[7]	LIANG Xiao, QIAN Haibing. Progress of the Relationship between Aquaporin 4 and Post-Stroke Cognitive Impairment [J]. Chinese Journal of Stroke, 2022, 17(12): 1385-1390.
[8]	WU Xiaoli, LIU Lixu. The Effect of Obesity on Prognosis of Stroke [J]. Chinese Journal of Stroke, 2022, 17(12): 1391-1395.
[9]	YI Luo, ZHOU Hongyu, QIU Xin, LI Zixiao, WANG Yongjun. DNA Methylation Changes in Atherosclerotic Diseases [J]. Chinese Journal of Stroke, 2022, 17(11): 1163-1170.
[10]	WANG Yubo, LI Zixiao, WANG Yongjun. Progress of the Relationship between Epigenetics and Oxidative Stress after Ischemic Stroke [J]. Chinese Journal of Stroke, 2022, 17(11): 1171-1177.
[11]	YAN Ran, MIN Yan, QUAN Kehua, LI Zixiao. Relationship between BDNF and SLC6A4 Gene Methylation and the Prognosis of Stroke [J]. Chinese Journal of Stroke, 2022, 17(11): 1178-1182.
[12]	CUI Lingyun, QIU Xin, ZHOU Hongyu, LI Zixiao, WANG Yongjun. Progress of the Relationship between DNA Methylation and Type 2 Diabetes [J]. Chinese Journal of Stroke, 2022, 17(11): 1183-1188.
[13]	DENG Yuhan, LIU Shuang, WANG Ziyao, WANG Yuxin, LIU Baohua. The Effect of Machine Learning Model for Predicting Stroke Risk in the General Population Based on Structured Data: A Systematic Review and Meta-Analysis [J]. Chinese Journal of Stroke, 2022, 17(11): 1189-1197.
[14]	LIU Guangliang, HAN Kaiyue, SU Wenlong, ZHANG Hao. Effects of Aerobic Cycling Training Intensity on Motor and Cardiopulmonary Fitness in Patients with Ischemic Stroke [J]. Chinese Journal of Stroke, 2022, 17(11): 1203-1208.
[15]	SUN Moyi, ZHANG Yumei, LIU Ran, ZHAO Yishuang. Effect of Rehabilitation at Different Timing after Stroke on Motor Function of Stroke Patients [J]. Chinese Journal of Stroke, 2022, 17(11): 1209-1215.